US5599552A
Expired / Lapsed
US
⏱️ 0.0 years remaining
Biodegradable polymer composition
Assignee: Tolmar Therapeutics Inc
•
Filing: 1994-05-26
•
Granted: 1997-02-04
•
Expires: 2014-05-26
Abstract
Abstract The invention is directed to a composition composed of a thermoplastic or thermosetting polymer which is capable of forming a biodegradable and/or bioerodible microporous, solid or gelatinous polymer matrix. The matrix is useful as an implant in animals for enhancing regeneration of cells and tissue, such as bone and nerve cells, or for delivery of biologically-active substances to tissue or organs. The composition is administered to an implant site as a liquid. The invention also includes a method of preventing and treating disorders and diseases, such as bone or nerve growth disorders, or of altering body functions such as birth control, using the compositions and implants of the invention.
Inventors
- 👤 Richard L. Dunn
- 👤 Arthur J. Tipton
- 👤 George L. Southard
- 👤 Jack A. Rogers
Bibliographic Details
Application Number
—
Jurisdiction
US
Data Source
google_patents
Last Synchronized
2026-10-24 02:01
CPC Classifications
A; A61; A61K; A61K9/00; A61K9/0012; A61K9/0019; A61K9/0024; A61L; A61L15/00; A61L15/07; A61L15/14; A61K31/00; A61K31/74; A61K33/00; A61K33/42; A61K47/00; A61K47/30; A61K47/34; A61K6/00; A61K6/50; A61K6/58; A61K9/0053; A61K9/0063; A61K9/14; A61K9/16; A61K9/1605; A61K9/1629; A61K9/1641; A61K9/1647; A61L27/00; A61L27/14; A61L27/16; A61L27/18; A61L27/22; A61L27/227; A61L27/50; A61L27/54; A61L27/56; A61L27/58; A61L31/00; A61L31/04; A61L31/043; A61L31/047; A61L31/14; A61L31/146; A61L31/148; A61L31/16; B; B29; B29C; B29C41/00; B29C41/02; B29C41/08; B29C41/12; B29C67/00; B29C67/02; B29C67/06; A61L2300/00; A61L2300/40; A61L2300/404; A61L2300/406; A61L2300/412; A61L2300/60; A61L2300/602; A61L2300/604
Claims Analysis
Total Claims: 30
Claim 1
Independent Claim
83 words
A composition suitable for forming an in situ solid implant in an animal, comprising: a formulation of a biodegradable, thermoplastic polymer that is insoluble in aqueous or body fluid, and an organic solvent that is miscible to dispersible in aqueous or body fluid, the composition being capable of coagulating or solidifying to form a solid microporous implant upon its contact with an aqueous or body fluid, the implant being a core surrounded by a skin, and the core and skin both being porous.
Claim 2
Dependent Claim
83 words
A composition suitable for forming an in situ solid implant in an animal, comprising: a formulation of a biodegradable, thermoplastic polymer that is insoluble in aqueous or body fluid, and an organic solvent that is miscible to dispersible in aqueous or body fluid, the composition being capable of coagulating or solidifying to form a solid microporous implant upon its contact with an aqueous or body fluid, the implant being a core surrounded by a skin, and the core and skin both being porous.
Claim 3
Dependent Claim
88 words
The composition of claim 1, wherein the organic solvent is a mixture of a first organic solvent that is a good solvent for the thermoplastic polymer, and a second organic solvent that is a poorer solvent or a non-solvent for the thermoplastic polymer; said first and second solvents included in said mixture at a ratio such that the thermoplastic polymer is soluble therein and coagulates to form a solid matrix upon placing the composition within the body and the dissipation or diffusion of the solvent into body fluid.
Claim 4
Independent Claim
79 words
A method of forming an implant suitable for altering a biological or physiological activity in an animal, comprising: administering to the animal composition in an amount effective to form in situ a solid implant, the composition being a liquid formulation of a biodegradable thermoset polymer that is insoluble in aqueous or body fluid and the composition undergoing curing to form a microporous matrix, the matrix being a core surrounded by a skin, the core and skin both being porous.
Claim 5
Independent Claim
79 words
A method of forming an implant suitable for altering a biological or physiological activity in an animal, comprising: administering to the animal composition in an amount effective to form in situ a solid implant, the composition being a liquid formulation of a biodegradable thermoset polymer that is insoluble in aqueous or body fluid and the composition undergoing curing to form a microporous matrix, the matrix being a core surrounded by a skin, the core and skin both being porous.
Claim 6
Dependent Claim
11 words
A composition according to claim 1, further comprising a pore-forming agent.
Claim 7
Dependent Claim
27 words
A composition according to claim 4, wherein the pore-forming agent is a sugar, salt, or water-soluble polymer, or water-insoluble substance that degrades to a water soluble substance.
Claim 8
Dependent Claim
49 words
A composition according to claim 1, wherein the thermoplastic polymer is selected from the group consisting of polylactides, polyglycolides, polycaprolactones, polyanhydrides, polyamides, polyurethanes, polyesteramides, polyorthoesters, polydioxanones, polyacetals, polyketals, polycarbonates, polyorthocarbonates, polyphosphazenes, polyhydroxybutyrates, polyhydroxyvalerates, polyalkylene oxalates, polyalkylene succinates, polyamino acids, polymethyl vinyl ether, and copolymers, terpolymers, and any combination thereof.
Claim 9
Dependent Claim
49 words
A composition according to claim 1, wherein the solvent is selected from the group consisting of N-methyl-2-pyrrolidone, 2-pyrrolidone, propylene carbonate, acetone, acetic acid, ethyl acetate, ethyl lactate, methyl acetate, methyl ethyl ketone, dimethylformamide, dimethyl sulfoxide, dimethyl sulfone, tetrahydrofuran, caprolactam, decylmethylsulfoxide, oleic acid, N,N-diethyl-m-toluamide, and 1-dodecylazacycloheptan-2-one, and any combination thereof.
Claim 10
Dependent Claim
13 words
A composition according to claim 1, further comprising at least one biologically-active agent.
Claim 11
Dependent Claim
22 words
A composition according to claim 8, wherein the biologically-active agent is a polypeptide derived from a natural, synthetic, or recombinant DNA source.
Claim 12
Dependent Claim
55 words
A composition according to claim 8, wherein the biologically-active agent is selected from a group consisting of anti-inflammatory agents, antibacterial agents, antiparasitic agents, antifungal agents, antiviral agents, anti-neoplastic agents, analgesic agents, anaesthetics, vaccines, central nervous system agents, growth factors, hormones, antihistamines, osteoinductive agents, cardiovascular agents, anti-ulcer agents, bronchodilators, birth control agents, and fertility enhancing agents.
Claim 13
Dependent Claim
49 words
A composition suitable for forming an in situ solid implant in an animal, comprising: a liquid formulation of a biodegradable thermoset polymer, the composition being capable of forming a solid microporous matrix, the matrix being a core surrounded by a skin, and the core and skin both being porous.
Claim 14
Dependent Claim
49 words
A composition suitable for forming an in situ solid implant in an animal, comprising: a liquid formulation of a biodegradable thermoset polymer, the composition being capable of forming a solid microporous matrix, the matrix being a core surrounded by a skin, and the core and skin both being porous.
Claim 15
Dependent Claim
23 words
The composition according to claim 1, wherein the thermoplastic polymer is a copolymer of lactide with glycolide or caprolactone, or a terpolymer thereof.
Claim 16
Independent Claim
109 words
A method of forming an implant suitable for altering a biological or physiological activity in an animal, comprising: administering to the animal a composition in an amount effective to form in situ a solid implant, the composition being a formulation of a biodegradable, bioerodable, biocompatible thermoplastic polymer that is insoluble in aqueous or body fluid, and an organic solvent that is miscible to dispersible in aqueous or body fluid, and the composition undergoing coagulation or solidification of the polymer and dispersion of the solvent into body fluid to form a solid microporous matrix, the matrix being a core surrounded by a skin, the core and skin both being porous.
Claim 17
Independent Claim
109 words
A method of forming an implant suitable for altering a biological or physiological activity in an animal, comprising: administering to the animal a composition in an amount effective to form in situ a solid implant, the composition being a formulation of a biodegradable, bioerodable, biocompatible thermoplastic polymer that is insoluble in aqueous or body fluid, and an organic solvent that is miscible to dispersible in aqueous or body fluid, and the composition undergoing coagulation or solidification of the polymer and dispersion of the solvent into body fluid to form a solid microporous matrix, the matrix being a core surrounded by a skin, the core and skin both being porous.
Claim 18
Dependent Claim
28 words
A composition according to claim 11, further comprising a pore-forming agent, an organic solvent that is miscible to dispersible in aqueous or body fluid, or a combination thereof.
Claim 19
Dependent Claim
21 words
A composition according to claim 14, wherein the pore-forming agent is a sugar, salt, or water-soluble polymer, or water-soluble organic solvent.
Claim 20
Dependent Claim
23 words
A composition according to claim 11, wherein the polymer is an acrylic ester-terminated biodegradable prepolymer capable of cross-linking to form a polymer matrix.
Claim 21
Dependent Claim
55 words
A composition according to claim 16, wherein the acrylic ester-terminated biodegradable prepolymer is selected from the group consisting of polylactides, polyglycolides, polycaprolactones, polyanhydrides, polyamides, polyurethanes, polyesteramides, polyorthoesters, polydioxanones, polyacetals, polyketals, polycarbonates, polyorthocarbonates, polyphosphazenes, polyhydroxybutyrates, polyhydroxyvalerates, polyalkylene oxalates, polyalkylene succinates, polymalic acid, polyamino acids, polymethyl vinyl ether, chitin, chitosan, and copolymers, terpolymers, and any combination thereof.
Claim 22
Dependent Claim
11 words
A composition according to claim 11, further comprising a curing agent.
Claim 23
Dependent Claim
30 words
A composition according to claim 11, further comprising at least one biologically-active agent that is free of functional groups that would interfere with the thermosetting reaction of the thermoset polymer.
Claim 24
Dependent Claim
22 words
A composition according to claim 19, wherein the biologically-active agent is a polypeptide derived from a natural, synthetic, or recombinant DNA source.
Claim 25
Dependent Claim
56 words
A composition according to claim 19, wherein the biologically-active agent is selected from a group consisting of anti-inflammatory agents, antibacterial agents, antiparasitic agents, antifungal agents, antiviral agents, anti-neoplastic agents, analgesic agents, anaesthetics, vaccines, central nervous system agents, growth factors, hormones, antihistamines, osteoinductive agents, cardiovascular agents, anti-ulcer agents, bronchodilators, vasodilators, birth control agents and fertility enhancing agents.
Claim 26
Dependent Claim
15 words
A method according to claim 13, wherein the implant is capable of enhancing tissue regeneration.
Claim 27
Dependent Claim
17 words
A method according to claim 13, wherein the implant is capable of filling in defects in tissue.
Claim 28
Dependent Claim
16 words
A method according to claim 13, wherein the composition further comprises at least one biologically-active agent.
Claim 29
Dependent Claim
57 words
A method according to claim 24, wherein the biologically active agent is selected from the group consisting of anti-inflammatory agents, antibacterial agents, antiparasitic agents, antifungal agents, antiviral agents, anti-neoplastic agents, analgesic agents, anaesthetics, vaccines, central nervous system agents, growth factors, hormones, antihistamines, osteoinductive agents, cardiovascular agents, anti-ulcer agents, vasodilators, bronchodilators, birth control agents, and fertility enhancing agents.
Claim 30
Dependent Claim
19 words
A method of claim 24, wherein the biologically-active agent alters the biological or physiological action of the reproductive system.
References Cited (Backward Citations)
US3068188A
Cited
US3975350A
Cited
US3919773A
Cited
US3949073A
Cited
US4761471A
Cited
US4294753A
Cited
US4789732A
Cited
US4451452A
Cited
US4619989A
Cited
US4455256A
Cited
US4526938A
Cited
US4904478A
Cited
US4795804A
Cited
US4932973A
Cited
US4526909A
Cited
US4563489A
Cited
US4596574A
Cited
EP0171173A1
Cited
US4894373A
Cited
US4939131A
Cited
US4595713A
Cited
US4857456A
Cited
US4921697A
Cited
US4780320A
Cited
US4919939A
Cited
US4946870A
Cited
US4942157A
Cited
US4863472A
Cited
US4905680A
Cited
US4902296A
Cited
EP0271831A2
Cited
EP0297535A2
Cited
US4912141A
Cited
WO1989001006A1
Cited
US4911931A
Cited
US4961707A
Cited
US4916241A
Cited
GB2223027A
Cited
US5250584A
Cited
US4938763A
Cited
US4938763B1
Cited
EP0430474A1
Cited
USPTO Annuity & Maintenance Windows
| Annuity Stage | Window Opens | Payment Deadline | Surcharge Period Until | Estimated Fee | Status |
|---|---|---|---|---|---|
| 3.5 Years (Year 4) | 2000-02-04 | 2000-08-05 | 2001-02-04 | $2000.00 | Window Closed / Lapsed |
| 7.5 Years (Year 8) | 2004-02-04 | 2004-08-05 | 2005-02-04 | $3760.00 | Window Closed / Lapsed |
| 11.5 Years (Year 12) | 2008-02-04 | 2008-08-05 | 2009-02-04 | $7700.00 | Window Closed / Lapsed |